To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines
Clinical trial NCT00366366 · COMPLETED
Trial details
- NCT number
- NCT00366366
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2002-09-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.